Purchases and Sales Made in Q2 2024 in Viridian Therapeutics, Inc.\De (VRDN)
This table provides information about the institutional ownership of Viridian Therapeutics, Inc.\De (VRDN) during Q2 2024. The information is specifically focused on institutions that hold shares of Viridian Therapeutics, Inc.\DE.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 13, 2024
Q2 2024
|
Profund Advisors LLC
|
SELL
|
- |
-36K- 57.17% |
$418K - $622K
|
27K
$568K
|
|
Aug 14, 2024
Q2 2024
|
Ghost Tree Capital, LLC
New York, NY |
SELL
|
- |
-37.3K- 5.97% |
$433K - $644K
|
588K
$12.4M
|
|
Aug 14, 2024
Q2 2024
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-38K- 8.66% |
$441K - $656K
|
401K
$8.43M
|
|
Aug 14, 2024
Q2 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-65.3K- 52.6% |
$757K - $1.13M
|
58.8K
$1.24M
|
|
Aug 12, 2024
Q2 2024
|
Eagle Asset Management Inc
St Petersburg, FL |
SELL
|
- |
-65.3K- 14.88% |
$758K - $1.13M
|
373K
$7.85M
|
|
Aug 13, 2024
Q2 2024
|
Pictet Asset Management Holding Sa
Carouge, V8 |
SELL
|
- |
-73.3K- 6.69% |
$851K - $1.27M
|
1.02M
$21.5M
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-149K- 39.31% |
$1.73M - $2.58M
|
230K
$4.84M
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-242K- 43.01% |
$2.81M - $4.18M
|
321K
$6.74M
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-242K- 43.01% |
$2.81M - $4.18M
|
321K
$6.74M
|
|
Aug 13, 2024
Q2 2024
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-264K- 64.54% |
$3.06M - $4.56M
|
145K
$3.05M
|
|
Aug 14, 2024
Q2 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-265K- 55.72% |
$3.07M - $4.57M
|
211K
$4.43M
|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
SELL
|
- |
-321K- 92.18% |
$3.72M - $5.54M
|
27.2K
$572K
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-718K- 94.14% |
$8.33M - $12.4M
|
44.7K
$939K
|
|
Aug 09, 2024
Q2 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-834K- 62.6% |
$9.67M - $14.4M
|
498K
$10.5M
|
|
Aug 14, 2024
Q2 2024
|
Great Point Partners LLC
Greenwich, CT |
SELL
|
- |
-835K- 62.55% |
$9.69M - $14.4M
|
500K
$10.5M
|
|
Aug 14, 2024
Q2 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-1.72M- 38.24% |
$19.9M - $29.6M
|
2.77M
$58.3M
|
|
Aug 14, 2024
Q2 2024
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-2.03M- 55.38% |
$23.5M - $35M
|
1.63M
$34.3M
|
|
Aug 14, 2024
Q2 2024
|
Paradigm Biocapital Advisors LP
New York, NY |
SELL
|
- |
-2.14M- 42.43% |
$24.8M - $36.9M
|
2.9M
$60.9M
|